Screener
Inspire Medical Systems INSP Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by Inspire Medical Systems in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: Inspire Medical Systems’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001609550-26-000023
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Adjustments to reconcile net (loss) earnings to net cash provided by (used in) operating activities: | ||
| Depreciation and amortization | 5,110 | 3,044 |
| Accretion of investment discount | (290) | (1,209) |
| Stock-based compensation expense | 30,689 | 31,056 |
| Deferred income tax expense | 1,009 | — |
| Provision for estimated credit losses | 186 | 311 |
| Other non-cash expenses | 548 | 512 |
| Changes in operating assets and liabilities: |
Item 1. Financial Statements.
FAQ
- What is Inspire Medical Systems's stock-based comp?
- Inspire Medical Systems (INSP) reported stock-based comp of $30.69M in Q1 2026.
- How has Inspire Medical Systems's stock-based comp changed year-over-year?
- Inspire Medical Systems's stock-based comp decreased by 1.2% year-over-year, from $31.06M to $30.69M.
- What is the long-term trend for Inspire Medical Systems's stock-based comp?
- Over 4 years (2021 to 2025), Inspire Medical Systems's stock-based comp has grown at a 49.4% compound annual growth rate (CAGR), from $26.18M to $130.27M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.
Ask your AI about Inspire Medical Systems's stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude